知名学者引用


        除了所发表论文的被引用频次、期刊质量能够彰显学者的学术影响力以外,被知名学者引用也是一项学术评价的重要指标。
        当前全球学者库认定的知名学者包括:诺贝尔奖、菲尔兹奖、图灵奖等奖项获得者,多个国家的院士,全球学者库“2023全球学者学术影响力排行版”入榜的前10万学者等。

Sheng,Sun MASSACHUSETTS General Hospital被知名学者引用:94人次(黄金会员以上可以申请导出本人论文被全部知名学者引用的数据)

1. Douglas C. Wallace 美国 University of Pennsylvania 1995美国科学院院士;2009美国医学院院士 Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts

2. James A. Wells 美国 University of California, San Francisco 1999美国科学院院士 Theranostic Targeting of CUB Domain-Containing Protein 1 (CDCP1) in Multiple Subtypes of Bladder Can..

3. Mardis, Elaine R. 美国 Ohio State University College of Medicine and Public Health 2019美国医学院院士 LINC00355 regulates p27(KIP) expression by binding to MENIN to induce proliferation in late-stage re..

4. Douglas C. Wallace 美国 University of Pennsylvania 1995美国科学院院士;2009美国医学院院士 Role of miR-2392 in driving SARS-CoV-2 infection

5. Santi, Daniel V. 美国 ProLynx Could a Long-Acting Prodrug of SN-38 be Efficacious in Sacituzumab Govitecan-Resistant Tumors?

6. Chatterjee, Kaushik 印度 Indian Institute Science Unravelling microRNA regulation and miRNA-mRNA regulatory networks in osteogenesis driven by 3D nano..

7. Seikaly, Hadi 加拿大 University of Alberta Algorithmically designed flaps in tongue reconstruction: a feasibility analysis

8. Matthew D,Galsky 美国 Tisch Cancer Institute Precision Medicine in Urothelial Carcinoma: Current Markers to Guide Treatment and Promising Future ..

9. Hope S,Rugo 美国 University of California-San Francisco Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth ..

10. Aditya,Bardia 美国 Harvard University Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth ..

11. Javier,Cortes 西班牙 IOB Institute oncology Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth ..

12. Schmid, Peter 英国 Queen Mary University of London Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth ..

13. Sara M,Tolaney 美国 Harvard University Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth ..

14. Debu,Tripathy 美国 University of Texas MD Anderson Cancer Center Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug co..

15. Funda,Meric-Bernstam 美国 University of Texas MD Anderson Cancer Center Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug co..

16. Christopher E,Mason 美国 Cornell University Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts

17. 王建华 中国 东北大学 Simultaneous Imaging of Multiple miRNAs in Mitochondria Controlled by Fluorescently Encoded Upconver..

18. Thomas,Bachelot 法国 Center LEON BERARD Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY ..

19. Veronique,Dieras 法国 Institute CURIE Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY ..

20. Fabrice,Andre 法国 Institute GUSTAVE ROUSSY Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY ..

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3